Accueil   Agenda - News   Toutes les news LIH joins forces with Advanced BioDesign to improve cancer immunotherapy      

LIH joins forces with Advanced BioDesign to improve cancer immunotherapy      

 

LIH TIME group strengthens the translational research in immuno-oncology by establishing a partnership with the French Biotech company “Advanced BioDesign"  

 

 

The Tumor Immunotherapy and Microenvironment (TIME) research group of the LIH Department of Oncology (DONC) teamed-up with Advanced BioDesign to develop innovative combinatorial immunotherapy approaches. The aim is to potentiate the effectiveness of immunotherapy and provide a ground-breaking approach to treat cancers.      

 
 

 

Lire le communiqué de presse